Newborn and Infant Nursing Reviews
Volume 6, Issue 2 , Pages 87-93 , June 2006

Surfactant

References 

  1. Kattwinkel J. Surfactant: evolving issues. Clin Perinatol. 1998;25:17–32
  2. Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child. 1959;97:517–523
  3. Jobe AH, Ikegami M. Biology of surfactant. Clin Perinatol. 2001;28:655–669
  4. Lewis JF, Jobe AH. Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis. 1993;147:218–233
  5. Sunshine P. The experts discuss emerging issues in surfactant replacement therapy. In: Proceeding from Round Table Discussion; B.W. Co. 1991;p. 1–51
  6. Poynter S, LeVine A. Surfactant biology and clinical application. Crit Care Clin. 2003;19:459–472
  7. Morton NS. Exogenous surfactant treatment for the adult respiratory distress syndrome? A historical perspective. Thorax. 1990;45:825–830
  8. Crouch E, Wright J. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol. 2001;63:521–524
  9. Suresh GK, Soll RF. Current surfactant use in premature infants. Clin Perinatol. 2001;28:671–694
  10. Ainsworth S, Milligan DWA. Surfactant therapy for respiratory distress syndrome in premature neonates. Am J Respir Med. 2002;1:417–433
  11. Merritt TA, Hallman M, Spragg R, Heldt G, Gilliard N. Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome. Drugs. 1989;38:591–611
  12. Coalson JJ, King RJ, Yang F, et al. SP-A deficiency in primate model of bronchopulmonary dysplasia with infection. Am J Respir Crit Care Med. 1995;151:854–866
  13. Taeusch HW. Treatment of acute (adult) respiratory distress syndrome. The Holy Grail of surfactant therapy. Biol Neonate. 2000;77(suppl 1):2–8
  14. Goerke J, Clements J. Alveolar surface tension and lung surfactant. In: Handbook of physiology. Bethesda, MD: Williams & Wilkins; 1986;p. 247–261
  15. Wiswell TE. Expanded uses of surfactant therapy. Clin Perinatol. 2001;28:695–711
  16. Bose C, Corbet A, Bose G, Garcia-Prats J, Lombardy L, Wold D, et al. Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant. J Pediatr. 1991;117:947–953
  17. Corbet A, Bucciarelli R, Goldman S, Mammel M, Wold D, Long W. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1. J Pediatr. 1991;118:277–284
  18. Corbet A, Long WA, Murphy DJ, Garcia-Prats JA, Lombardy LR, Wold DE. Reduced mortality in small premature infants treated at birth with a single dose of synthetic surfactant. J Paediatr Child Health. 1991;27:245–249
  19. Long W, Corbet A, Cotton R, Courtney S, Mc Guiness G, Walter D, et al. A controlled trial of synthetic surfactant in infants weighing 1250g or more with respiratory distress syndrome The American Exosurf Neonatal Study Group 1 and the Canadian Exosurf Neonatal Study Group. N Engl J Med. 1991;325:1696–1703
  20. Horbar J, Wright LL, Soll RF, et al. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr. 1993;123:757–766
  21. Hudak M, Farrell EE, Rosenberg AA, et al. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome. J Pediatr. 1996;128:396–406
  22. Vermont Oxford Network . A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant in the treatment of neonatal respiratory distress syndrome. Pediatrics. 1996;97:1–6
  23. Creuwels LAJM, van Golde LMG, Haagsman HP. The pulmonary surfactant system: biochemical and clinical aspects. Lung. 1997;175:1–39
  24. Enhorning G, Shennan A, Possmayer F, Dunn M, Chen CP, Milligan J. Prevention of neonatal respiratory distress syndrome by tracheal administration of surfactant: a randomized clinical trial. Pediatrics. 1985;76:145–153
  25. Dekowski SA, Holtzman RB. Surfactant replacement therapy. Pediatr Clin North Am. 1998;45:549–572
  26. Khammash H, Perlman M, Wojtulewicz J, Dunn M. Surfactant therapy in full-term neonates with severe respiratory failure. Pediatrics. 1993;92:135–139
  27. Shapiro D, Notter R, Morin F, et al. Double blind, randomized trial of a calf lung surfactant extract, administered at birth to very premature infants for prevention of respiratory distress syndrome. Pediatrics. 1986;76:593–595
  28. Vallis-i-Soler A, Fernandez-Ruanova B, Lopez-Heredia y Goya J, et al. A randomized comparison of surfactant dosing via a dual-lumen endotracheal tube in respiratory distress syndrome. Pediatrics. 1998;101:1–5
  29. Anzueto A, Baughman RP, Guntupalli KK, et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med. 1996;334:1417–1421
  30. Cosmi E, LaTorre R, Piazze JJ, et al. Intraamniotic surfactant for prevention of neonatal respiratory distress syndrome (IRDS). Eur J Obstet Gynecol Reprod Biol. 1997;71:1–39
  31. Lisawa J, Pietrasik D, Zwolinski J, Gierowska-Bogusz B, Lewandowski L, Chazan B. Intraamniotic surfactant supply as RDS prevention. Med Wieku Rozwoj. 2003;7(suppl 1):255–260
  32. Kattwinkel J, Robinson M, Bloom BT, Delmore P, Ferguson JE. Technique for intrapartum administration of surfactant without requirement for an endotracheal tube. J Perinatol. 2004;24:360–365
  33. Cummings JJ, Holm BA, Hudak ML, Hudak BB, Ferguson WH, Egan EA. A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs. Am Rev Respir Dis. 1992;145(5):999–1004
  34. Ikegami M, Kallapur S, Michna J, Jobe AH. Lung injury and surfactant metabolism after hyperventilation of premature lambs. Pediatr Res. 2000;47:398–404
  35. Schurch S. Surface tension properties of surfactant. Clin Perinatol. 1993;20:669–682
  36. Seeger W, Grube C, Gunther A, Schmidt R. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J. 1993;6:971–977
  37. Fujiwara T, Chida S, Watabe Y, Maeta H, Morita T, Abe T. Artificial surfactant in hyaline membrane disease. Lancet. 1980;315(8159):55–59
  38. Hall S, Venkitaraman AR, Whitsett JA, Holm BA, Notter RH. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants. Am Rev Respir Dis. 1992;145(1):24–30
  39. Halliday J. Natural vs synthetic surfactants in neonatal respiratory distress syndrome. Drugs. 1996;51:226–237
  40. Bloom B. Comparison of Infasurf (Calf Lung Surfactant Extract) to Survanta (Beractant) in the Treatment and Prevention of Respiratory Distress Syndrome. Pediatrics. 1997;100:31–38
  41. Speer C, Gefeller O, Groneck P, et al. Randomized clinical trial of surfactant therapy for neonatal respiratory distress syndrome: comparison of two treatment regimens with natural surfactant preparations. Arch Dis Child. 1995;72:F8–F13
  42. Fox GF, Sorthinathan U. The choice of surfactant for treatment of respiratory distress syndrome in preterm infants: a review of the evidence. Infant. 2005;1:8–12
  43. Jobe AH. Pathophysiology of respiratory distress syndrome. In:  Polin RA,  Fox WW editor. Fetal and neonate physiology. Philadelphia (PA): W.B. Saunders; 1992;p. 995–1001
  44. Findlay R, Tauesch W, Walther F. Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics. 1996;97:48–52
  45. Harms K, Herting E. Successful surfactant replacement therapy in two infants with ARDS due to chlamydial pneumonia. Respiration. 1994;61:348–352
  46. Pandit PB, Dunn MS, Kelly EN, et al. Surfactant replacement in neonates with early chronic lung disease. Pediatrics. 1995;95:851–854
  47. Lotze A, Mitchell BR, Bulas DI, Zola EM, Shalwitz RA, Gunkel JH. Multicenter study of surfactant (Beractant) use in the treatment of term infants with severe respiratory failure. J Pediatr. 1998;132:40–47
  48. Auten RL, Notter RH, Kendig JW, Davis JM, Shapiro DL. Surfactant treatment of full-term newborns with respiratory failure. Pediatrics. 1991;87:101–107
  49. Moreno M, Lopez-Herce J, Alcaraz A, Carrillo A. Exogenous surfactant therapy for acute respiratory distress in infancy. Intensive Care Med. 1996;22:87–88
  50. Herting E, Gefeller O, Land M, van Sonderen L, Harms K, Robertson B and the Members of the Collaborative European Multicenter Study Group. Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Pediatrics. 2000;106:957–965
  51. Greenough A. Expanded use of surfactant replacement therapy. Eur J Pediatr. 2000;159:635–640
  52. Suzuki Y. Effect of protein, cholesterol and phosphatidylglycerol on the surface activity of the lipid-protein complex reconstituted from pig pulmonary surfactant. J Lipid Res. 1982;23:62–69
  53. Antal J, Divis LT, Erzurum SC, Wiedemann HP, Thomassen MJ. Surfactant suppresses NF-k B activation in human monocytic cells. Am J Respir Cell Mol Biol. 1996;14:374–379
  54. Rubin BK, Ramirez O, King M. Mucus rheology and transport in neonatal respiratory distress syndrome and the effect of surfactant therapy. Chest. 1992;101:1080–1085
  55. Alabaman V, Sood SL, Finn KC. Physiologic response and lung distribution of lavage versus bolus Exosurf in piglets with acute lung injury. Am J Respir Crit Care Med. 1996;153:1838–1843
  56. Cochrane CG, Revak SD, Merritt TA, et al. Bronchoalveolar lavage with KL4-surfactant in models of meconium aspiration syndrome. Pediatr Res. 1998;44:705–715
  57. Ohama Y, Itakura Y, Koyama N, Eguchi H, Ogawa Y. Effect of surfactant lavage in a rabbit model of meconium aspiration syndrome. Acta Paediatr Jpn. 1994;36(3):236–238
  58. Baughman R, Sternberg R, Jull W. Decreased surfactant protein A in patients with bacterial pneumonia. Am Rev Respir Dis. 1993;147:653–657
  59. Levine AM, Lotze A, Stanley S, Stroud C, O'Donnell R, Whitsett J, et al. Surfactant content in children with inflammatory lung disease. Crit Care Med. 1996;24:1062–1067
  60. Holm BA, Keicher L, Liu MY, Sokolowski J, Enhorning G. Inhibition of pulmonary surfactant function by phospholipases. J Appl Physiol. 1991;71(1):317–321
  61. Wilson D, Zaritsky A, Bauman LA, Dockery K, James RL, Conrad D, et al. Instillation of calf lung surfactant extract (calfactant) is beneficial in pediatric acute hypoxemic respiratory failure. Crit Care Med. 1999;27(1):188–195
  62. Wilson DF, Jiao JH, Bauman LA, Zaritsky A, Craft H, Dockery K, et al. Calf's lung surfactant extract in acute hypoxemic respiratory failure in children. Crit Care Med. 1996;24(6):1316–1322
  63. Tibby S, Hatherill M, Wright S, Wilson P, Postle A, Murdoch L. Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med. 2000;162:1251–1256
  64. Song GW, Robertson B, Curstedt T, Gan XZ, Huang WX. Surfactant treatment in experimental escherichia coli pneumonia. Acta Anaesthesiol Scand. 1996;40:1154–1160
  65. van Daal GJ, So KL, Gommers D, Eijking EP, Fievez RB, Sprenger MJ, et al. Intratracheal surfactant administration restores gas exchange in experimental adult respiratory distress syndrome associated with viral pneumonia. Anesth Analg. 1991;72:589–595
  66. van Daal GJ, Bos AH, Eijking EP, Gommers D, Hannappel E, Lachman B. Surfactant replacement therapy improves pulmonary mechanics in end stage influenza A pneumonia. Am Rev Respir Dis. 1992;145:859–863
  67. Pandit PB, Dunn MS, Colucci EA. Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage. Pediatrics. 1995;95:32–36
  68. Bissinger R, Carlson C, Hulsey T, Eicher D. Secondary surfactant deficiency in neonates. J Perinatol. 2004;24:663–666

PII: S1527-3369(06)00041-9

doi: 10.1053/j.nainr.2006.03.007

Newborn and Infant Nursing Reviews
Volume 6, Issue 2 , Pages 87-93 , June 2006

Article Tools